Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Over 230,000 bottles of the antidepressant duloxetine (Cymbalta) have been recalled due to the presence of a potential ...

During mitosis, the condensin I and II complexes compact chromatin into chromosomes. Loss of the chromokinesin, KIF4A, results in reduced condensin I association with chromosomes, but the molecular ...

Here, we define the molecular mechanism targeting the condensin SMC complex to specific chromosomal regions in budding yeast. A conserved pocket on the condensin HAWK subunit Ycg1 binds to chromosomal ...

It operates via a molecular "cut and paste" mechanism driven by special proteins, known as recombinases. The integron system has been researched a lot. Some bacteria gain new resistance very fast ...

The FDA reports that the recall was initiatiated after it was discovered that the products contained elevated levels of N-nitroso-duloxetine (NDXT), which has been identified as potentially ...

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...

KYIV, Dec 15 (Reuters) - Ukrainian President Volodymyr Zelenskiy said on Saturday he had instructed his government to set up supply mechanisms to deliver together with international organisations ...

A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially cancer-causing chemical. More than 233,000 bottles of duloxetine ...

More than 233,000 bottles of duloxetine, an antidepressant, are being recalled for containing a chemical that increases risk of cancer, the U.S. Food and Drug Administration announced. The FDA had ...

More than 233,000 bottles of the antidepressant duloxetine have been recalled because of a chemical that contains the risk of cancer, public health officials said. The U.S. Food and Drug ...